BriaCell Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for BriaCell Therapeutics (BCTX).

Price Target Range — 7 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$40Upside to Avg. PT+920.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 27, 2025	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$32→$40
Apr 22, 2025	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$32
Feb 3, 2025	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$15→$32
Dec 12, 2024	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$15
Dec 3, 2024	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$15
Oct 3, 2024	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$15
Sep 19, 2024	HC Wainwright & Co.	Emily Bodnar	PT Cut	Buy	$18→$15
Sep 11, 2024	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$18
Jun 4, 2024	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$18
May 24, 2024	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$18
Dec 28, 2023	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$18

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Raises Price Target to $40

HC Wainwright & Co. analyst Emily Bodnar maintains BriaCell Therapeutics (NASDAQ:BCTX) with a Buy and raises the price target from $32 to $40.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $32 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates BriaCell Therapeutics (NASDAQ:BCTX) with a Buy and maintains $32 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Raises Price Target to $32

HC Wainwright & Co. analyst Emily Bodnar maintains BriaCell Therapeutics (NASDAQ:BCTX) with a Buy and raises the price target from $15 to $32.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates BriaCell Therapeutics (NASDAQ:BCTX) with a Buy and maintains $15 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates BriaCell Therapeutics (NASDAQ:BCTX) with a Buy and maintains $15 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates BriaCell Therapeutics (NASDAQ:BCTX) with a Buy and maintains $15 price target.

Benzinga Newsdesk

BriaCell Therapeutics Corp

ニュース

パートナーシップ

ベンジンガ・グローバル

BriaCell Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Raises Price Target to $40

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $32 Price Target

PRO
HC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Raises Price Target to $32

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

People Also Watch

People Also Watch

BriaCell Therapeutics Corp

ニュース

パートナーシップ

ベンジンガ・グローバル

BriaCell Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Raises Price Target to $40

PROHC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $32 Price Target

PROHC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Raises Price Target to $32

PROHC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

PROHC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

PROHC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Raises Price Target to $40

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $32 Price Target

PRO
HC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Raises Price Target to $32

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target